Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancers
Latest Information Update: 16 Mar 2020
At a glance
- Drugs Letrozole (Primary) ; Antineoplastics
- Indications Breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- 15 Mar 2020 Status changed from recruiting to discontinued.
- 13 Jul 2015 Planned number of patients changed from 100 to 70 as reported by University Hospital Medical Information Network - Japan record.
- 20 Jul 2012 New trial record